Measuring health-related quality of life in MSA

The MSA-QoL

Anette Schrag, Caroline Selai, Chris Mathias, Phillip Anson Low, Jeremy Hobart, Niall Brady, Niall Patrick Quinn

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The objective of this study was to develop a new patient-reported outcome measure for patients with multiple system atrophy (MSA) and to test its psychometric properties. There were three stages. First, a pool of potential scale items was generated from in-depth patient interviews. Second, these items were administered, in the form of a questionnaire, to a sample of people with MSA and traditional psychometric methods used to develop a rating scale satisfying standard criteria for reliability and validity. Third, the psychometric properties of the rating scale were examined in a second sample. In stage one, a pool of 105 items was generated from 20 patient interviews. In stage two, a scale with three subscales (motor, 14 items; nonmotor, 12 items; emotional/social functioning, 14 items), satisfying standard criteria for reliability and validity, was developed from the response data of 317 patients with MSA (response rate 71%). In stage three, the scale was examined in 286 people with MSA. Missing data were low, scores in both subscales were evenly distributed, and floor and ceiling effects were small. Reliability was high (Cronbach's alpha 0.83-0.93; test-retest ICC 0.88-0.92). Validity was supported by the interscale correlations (r = 0.47-0.59), known group differences, and the magnitude and pattern of correlations with four other rating scales, disease severity, and disease duration. In conclusion, the patient-rated MSA health-related Quality of life scale (MSA-QoL) may be a suitable patient-reported scale for use in clinical trials and studies in MSA.

Original languageEnglish (US)
Pages (from-to)2332-2338
Number of pages7
JournalMovement Disorders
Volume22
Issue number16
DOIs
StatePublished - Dec 2007

Fingerprint

Multiple System Atrophy
Quality of Life
Psychometrics
Reproducibility of Results
Interviews
Clinical Trials

Keywords

  • Development
  • Multiple system atrophy
  • Quality of life
  • Scale
  • Validation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Schrag, A., Selai, C., Mathias, C., Low, P. A., Hobart, J., Brady, N., & Quinn, N. P. (2007). Measuring health-related quality of life in MSA: The MSA-QoL. Movement Disorders, 22(16), 2332-2338. https://doi.org/10.1002/mds.21649

Measuring health-related quality of life in MSA : The MSA-QoL. / Schrag, Anette; Selai, Caroline; Mathias, Chris; Low, Phillip Anson; Hobart, Jeremy; Brady, Niall; Quinn, Niall Patrick.

In: Movement Disorders, Vol. 22, No. 16, 12.2007, p. 2332-2338.

Research output: Contribution to journalArticle

Schrag, A, Selai, C, Mathias, C, Low, PA, Hobart, J, Brady, N & Quinn, NP 2007, 'Measuring health-related quality of life in MSA: The MSA-QoL', Movement Disorders, vol. 22, no. 16, pp. 2332-2338. https://doi.org/10.1002/mds.21649
Schrag A, Selai C, Mathias C, Low PA, Hobart J, Brady N et al. Measuring health-related quality of life in MSA: The MSA-QoL. Movement Disorders. 2007 Dec;22(16):2332-2338. https://doi.org/10.1002/mds.21649
Schrag, Anette ; Selai, Caroline ; Mathias, Chris ; Low, Phillip Anson ; Hobart, Jeremy ; Brady, Niall ; Quinn, Niall Patrick. / Measuring health-related quality of life in MSA : The MSA-QoL. In: Movement Disorders. 2007 ; Vol. 22, No. 16. pp. 2332-2338.
@article{2c7d78b757c84637ad9ee61db4965868,
title = "Measuring health-related quality of life in MSA: The MSA-QoL",
abstract = "The objective of this study was to develop a new patient-reported outcome measure for patients with multiple system atrophy (MSA) and to test its psychometric properties. There were three stages. First, a pool of potential scale items was generated from in-depth patient interviews. Second, these items were administered, in the form of a questionnaire, to a sample of people with MSA and traditional psychometric methods used to develop a rating scale satisfying standard criteria for reliability and validity. Third, the psychometric properties of the rating scale were examined in a second sample. In stage one, a pool of 105 items was generated from 20 patient interviews. In stage two, a scale with three subscales (motor, 14 items; nonmotor, 12 items; emotional/social functioning, 14 items), satisfying standard criteria for reliability and validity, was developed from the response data of 317 patients with MSA (response rate 71{\%}). In stage three, the scale was examined in 286 people with MSA. Missing data were low, scores in both subscales were evenly distributed, and floor and ceiling effects were small. Reliability was high (Cronbach's alpha 0.83-0.93; test-retest ICC 0.88-0.92). Validity was supported by the interscale correlations (r = 0.47-0.59), known group differences, and the magnitude and pattern of correlations with four other rating scales, disease severity, and disease duration. In conclusion, the patient-rated MSA health-related Quality of life scale (MSA-QoL) may be a suitable patient-reported scale for use in clinical trials and studies in MSA.",
keywords = "Development, Multiple system atrophy, Quality of life, Scale, Validation",
author = "Anette Schrag and Caroline Selai and Chris Mathias and Low, {Phillip Anson} and Jeremy Hobart and Niall Brady and Quinn, {Niall Patrick}",
year = "2007",
month = "12",
doi = "10.1002/mds.21649",
language = "English (US)",
volume = "22",
pages = "2332--2338",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "16",

}

TY - JOUR

T1 - Measuring health-related quality of life in MSA

T2 - The MSA-QoL

AU - Schrag, Anette

AU - Selai, Caroline

AU - Mathias, Chris

AU - Low, Phillip Anson

AU - Hobart, Jeremy

AU - Brady, Niall

AU - Quinn, Niall Patrick

PY - 2007/12

Y1 - 2007/12

N2 - The objective of this study was to develop a new patient-reported outcome measure for patients with multiple system atrophy (MSA) and to test its psychometric properties. There were three stages. First, a pool of potential scale items was generated from in-depth patient interviews. Second, these items were administered, in the form of a questionnaire, to a sample of people with MSA and traditional psychometric methods used to develop a rating scale satisfying standard criteria for reliability and validity. Third, the psychometric properties of the rating scale were examined in a second sample. In stage one, a pool of 105 items was generated from 20 patient interviews. In stage two, a scale with three subscales (motor, 14 items; nonmotor, 12 items; emotional/social functioning, 14 items), satisfying standard criteria for reliability and validity, was developed from the response data of 317 patients with MSA (response rate 71%). In stage three, the scale was examined in 286 people with MSA. Missing data were low, scores in both subscales were evenly distributed, and floor and ceiling effects were small. Reliability was high (Cronbach's alpha 0.83-0.93; test-retest ICC 0.88-0.92). Validity was supported by the interscale correlations (r = 0.47-0.59), known group differences, and the magnitude and pattern of correlations with four other rating scales, disease severity, and disease duration. In conclusion, the patient-rated MSA health-related Quality of life scale (MSA-QoL) may be a suitable patient-reported scale for use in clinical trials and studies in MSA.

AB - The objective of this study was to develop a new patient-reported outcome measure for patients with multiple system atrophy (MSA) and to test its psychometric properties. There were three stages. First, a pool of potential scale items was generated from in-depth patient interviews. Second, these items were administered, in the form of a questionnaire, to a sample of people with MSA and traditional psychometric methods used to develop a rating scale satisfying standard criteria for reliability and validity. Third, the psychometric properties of the rating scale were examined in a second sample. In stage one, a pool of 105 items was generated from 20 patient interviews. In stage two, a scale with three subscales (motor, 14 items; nonmotor, 12 items; emotional/social functioning, 14 items), satisfying standard criteria for reliability and validity, was developed from the response data of 317 patients with MSA (response rate 71%). In stage three, the scale was examined in 286 people with MSA. Missing data were low, scores in both subscales were evenly distributed, and floor and ceiling effects were small. Reliability was high (Cronbach's alpha 0.83-0.93; test-retest ICC 0.88-0.92). Validity was supported by the interscale correlations (r = 0.47-0.59), known group differences, and the magnitude and pattern of correlations with four other rating scales, disease severity, and disease duration. In conclusion, the patient-rated MSA health-related Quality of life scale (MSA-QoL) may be a suitable patient-reported scale for use in clinical trials and studies in MSA.

KW - Development

KW - Multiple system atrophy

KW - Quality of life

KW - Scale

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=38549157541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549157541&partnerID=8YFLogxK

U2 - 10.1002/mds.21649

DO - 10.1002/mds.21649

M3 - Article

VL - 22

SP - 2332

EP - 2338

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 16

ER -